Rhythm (Nasdaq: IRTC) shares rose slightly before hours today on fourth-quarter results that beat the consensus forecast.

Pulse BioSciences’ CTO knows what it takes to create successful medtech and sometimes, it takes partnering with the competition.

Bloomberg reports that Johnson & Johnson (NYSE: JNJ) aims to sell its DePuy Synthes Orthopaedics business for more than $20 billion.

Simpson Interventions announced that it closed its Series C financing and rebranded to Elumn8 Medical. The Campbell, ...

Medtronic announced the first U.S. commercial cases for its Hugo soft-tissue robotic surgery system, conducted at Cleveland ...

Catheter Precision announced today that it agreed to divest its atherectomy catheter technologies to an unnamed strategic acquirer.

The FDA cleared the Signa Sprint with Freelium, Signa Bolt and Signa One. Signa Sprint is a 1.5T sealed magnet MRI system, while Signa Bolt is an advanced 3T MRI scanner. Signa One offers an AI-driven ...

Medtronic continues to expand the growth opportunities for its hypertension-treating Symplicity Spyral renal denervation system.

GE HealthCare today announced a $35 million collaboration with the Biomedical Advanced Research and Development Authority ...

Medical 21 has filed a Form S-1 with the U.S. SEC to initiate the process of an initial public offering (IPO).

W.L. Gore & Associates announced today that it completed its acquisition of heart implant maker Conformal Medical.

The Financial Times reports that Danaher is on the verge of acquiring Masimo in a deal worth approximately $9.9 billion.